OCULEVE, INC.
33Patents
33Active
33Granted
56Portfolio score
Filing activity: Apr 6, 2012 → Apr 17, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8996137B2 | Nasal stimulation devices and methods | Human Necessities | 95 | Active |
| US9440065B2 | Nasal stimulation devices and methods | Human Necessities | 60 | Active |
| US9265956B2 | Devices and methods for treating dry eye in animals | Human Necessities | 60 | Active |
| US9737702B2 | Nasal stimulation devices and methods | Human Necessities | 51 | Active |
| US9687652B2 | Stimulation patterns for treating dry eye | Human Necessities | 46 | Active |
| US9821159B2 | Stimulation devices and methods | Human Necessities | 44 | Active |
| US9770583B2 | Polymer formulations for nasolacrimal stimulation | Emerging Cross-Sectional Technologies | 34 | Active |
| US9737712B2 | Stimulation devices and methods for treating dry eye | Human Necessities | 34 | Active |
| US9764150B2 | Contact lens for increasing tear production | Human Necessities | 34 | Active |
| US10252048B2 | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies | Human Necessities | 33 | Active |
| US9717627B2 | Implant delivery devices, systems, and methods | Human Necessities | 32 | Active |
| US10155108B2 | Nasal stimulation devices and methods | Human Necessities | 31 | Active |
| USD826420S1 | Nasal stimulator device | General | 29 | Active |
| US10238861B2 | Nasal stimulation devices and methods for treating dry eye | Human Necessities | 24 | Active |
| US9956397B2 | Polymer Formulations for nasolacrimal stimulation | Emerging Cross-Sectional Technologies | 24 | Active |
| US10207108B2 | Implantable nasal stimulator systems and methods | Human Necessities | 16 | Active |
| USD837396S1 | Nasal stimulator probe | General | 14 | Active |
| USD907791S1 | Nasal stimulator body | General | 8 | Active |
| US10112048B2 | Stimulation devices and methods for treating dry eye | Human Necessities | 8 | Active |
| US10835748B2 | Stimulation devices and methods | Human Necessities | 4 | Active |
| US10426958B2 | Intranasal stimulation for enhanced release of ocular mucins and other tear proteins | Human Necessities | 3 | Active |
| US10918864B2 | Intranasal stimulation for treatment of meibomian gland disease and blepharitis | Human Necessities | 2 | Active |
| US10940310B2 | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies | Human Necessities | 1 | Active |
| US10780273B2 | Stimulation devices and methods for treating dry eye | Human Necessities | 1 | Active |
| US10967173B2 | Nasal stimulation devices and methods for treating dry eye | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.